Literature DB >> 10201982

Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells.

R Krzysiek1, E A Lefèvre, W Zou, A Foussat, J Bernard, A Portier, P Galanaud, Y Richard.   

Abstract

We show herein that B cell Ag receptor (BCR) triggering, but not stimulation by CD40 mAb and/or IL-4, rapidly induced the coordinated expression of two closely related T cell chemoattractants, macrophage inflammatory protein-1 beta (MIP-1 beta) and MIP-1 alpha, by human B cells. Naive, memory, and germinal center B cells all produced MIP-1 alpha/beta in response to BCR triggering. In contrast to MIP-1 alpha/beta, IL-8, which is spontaneously produced by germinal center B cells but not by naive and memory B cells, was not regulated by BCR triggering. Culturing follicular dendritic cell-like HK cells with activated B cells did not regulate MIP-1 alpha/beta production, but it did induce production of IL-8 by HK cells. Microchemotaxis assays showed that CD4+CD45RO+ T cells of the effector/helper phenotype actively migrated along a chemotactic gradient formed by BCR-stimulated B cells. This effect was partially blocked by anti-MIP-1 beta and anti-CC chemokine receptor 5 Ab, but not by anti-MIP-1 alpha Ab suggesting that MIP-1 beta plays a major role in this chemoattraction. Since maturation of the B cell response to a peptide Ag is mostly dependent on the availability of T cell help, the ability of Ag-stimulated B cells to recruit T cells via MIP-1 alpha/beta, may represent one possible mechanism enabling cognate interactions between rare in vivo Ag-specific T and B cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201982

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma.

Authors:  Koichi Takahashi; Mariela Sivina; Julia Hoellenriegel; Yasuhiro Oki; Fredrick B Hagemeister; Luis Fayad; Jorge E Romaguera; Nathan Fowler; Michelle A Fanale; Larry W Kwak; Felipe Samaniego; Sattva Neelapu; Lianchun Xiao; Xuelin Huang; Hagop Kantarjian; Michael J Keating; William Wierda; Kai Fu; Wing C Chan; Julie M Vose; Susan O'Brien; Richard E Davis; Jan A Burger
Journal:  Br J Haematol       Date:  2015-09-11       Impact factor: 6.998

2.  CD23+ CD21(high) CD1d(high) B cells in inflamed lymph nodes are a locally differentiated population with increased antigen capture and activation potential.

Authors:  Safiehkhatoon Moshkani; Igor I Kuzin; Funmilola Adewale; Johan Jansson; Iñaki Sanz; Edward M Schwarz; Andrea Bottaro
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

3.  High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.

Authors:  Jan A Burger; Maite P Quiroga; Elena Hartmann; Andrea Bürkle; William G Wierda; Michael J Keating; Andreas Rosenwald
Journal:  Blood       Date:  2008-12-12       Impact factor: 22.113

Review 4.  B cell receptor signaling in chronic lymphocytic leukemia.

Authors:  Jan A Burger; Nicholas Chiorazzi
Journal:  Trends Immunol       Date:  2013-08-05       Impact factor: 16.687

5.  Corruption of human follicular B-lymphocyte trafficking by a B-cell superantigen.

Authors:  Gwenoline Borhis; Muriel Viau; Gamal Badr; Yolande Richard; Moncef Zouali
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

6.  Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration.

Authors:  J Hoellenriegel; G P Coffey; U Sinha; A Pandey; M Sivina; A Ferrajoli; F Ravandi; W G Wierda; S O'Brien; M J Keating; J A Burger
Journal:  Leukemia       Date:  2012-02-07       Impact factor: 11.528

7.  Expanded CD23(+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy.

Authors:  Jie Li; Igor Kuzin; Safiehkhatoon Moshkani; Steven T Proulx; Lianping Xing; Denise Skrombolas; Robert Dunn; Iñaki Sanz; Edward M Schwarz; Andrea Bottaro
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

8.  Distinct TLR-mediated cytokine production and immunoglobulin secretion in human newborn naïve B cells.

Authors:  Matthew A Pettengill; Simon D van Haren; Ning Li; David J Dowling; Ilana Bergelson; Jop Jans; Gerben Ferwerda; Ofer Levy
Journal:  Innate Immun       Date:  2016-06-01       Impact factor: 2.680

9.  The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo.

Authors:  Sabine Ponader; Shih-Shih Chen; Joseph J Buggy; Kumudha Balakrishnan; Varsha Gandhi; William G Wierda; Michael J Keating; Susan O'Brien; Nicholas Chiorazzi; Jan A Burger
Journal:  Blood       Date:  2011-12-16       Impact factor: 22.113

10.  Independent expression of the two paralogous CCL4 genes in monocytes and B lymphocytes.

Authors:  Jun Lu; Marek Honczarenko; Steven R Sloan
Journal:  Immunogenetics       Date:  2003-12-13       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.